High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study
Year: 2025
Type: article
Study design: Observational Study
Authors: Živa Šubic, David Drobne, Gregor Novak
Institutions: University of Ljubljana, Ljubljana University Medical Centre
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417184206